Efficacy and safety of PAC‐14028 cream – a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild‐to‐moderate atopic dermatitis: a phase IIb randomized trial

BACKGROUND: Transient receptor potential vanilloid subfamily, member 1 (TRPV1) may play an important role in pruritus and inflammation induction in atopic dermatitis (AD). The treatment effect of TRPV1 antagonist via topical application in patients with AD remains unknown. OBJECTIVES: To assess the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Y.W., Won, C.‐H., Jung, K., Nam, H.‐J., Choi, G., Park, Y.‐H., Park, M., Kim, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850419/
https://www.ncbi.nlm.nih.gov/pubmed/30623408
http://dx.doi.org/10.1111/bjd.17455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850419/
https://www.ncbi.nlm.nih.gov/pubmed/30623408
http://dx.doi.org/10.1111/bjd.17455

Ejemplares similares